Every new paper in 280 characters, with how strong the evidence is and what readers question about it. Free to read.
Cardiology · JAMA Cardiol · 2026-11-01
RCTn = 900
Dalén et al. No-Touch vs Conventional Vein Grafts in Coronary Surgery: Seven-Year Clinical Outcomes of the SWEDEGRAFT Randomized Clinical TrialCardiology · JAMA Cardiol · 2026-11-01
Secondary analysisn = 17,604
Ostrominski et al. Efficacy and Safety of Semaglutide According to Frailty Status: A Post Hoc Analysis of the SELECT Randomized Clinical TrialCardiology · Lancet · 2026-10-29
Meta-analysisn = 110,933 presentations
Boeddinghaus et al. Performance of 0/1 h versus 0/3 h pathways in patients with suspected myocardial infarction: a systematic review and individual participant data meta-analysis of randomised controlled trialsCardiology · JAMA Cardiol · 2026-10-01
Secondary analysisn = 3,102
Taggart et al. Long-Term Outcomes Following Bilateral vs Single Internal Thoracic Artery Grafts: A Secondary Analysis of a Randomized Clinical TrialCardiology · Lancet · 2026-09-30
RCTn = 2,749
Klein et al. Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trialCardiology · N Engl J Med · 2026-08-29
RCTn = 3,170
Lee et al. Targeted Use of Computed Tomographic Coronary Angiography in Acute Chest PainCardiology · N Engl J Med · 2026-08-29
RCTn = 1,823
Biscaglia et al. Complete Revascularization Guided by Functional Coronary Angiography in STEMICardiology · N Engl J Med · 2026-08-29
RCTn = 17,095
Omerovic et al. Prasugrel versus Ticagrelor in Acute Coronary SyndromesCardiology · N Engl J Med · 2026-08-29
RCTn = 14,194
Gibson et al. Milvexian with Antiplatelet Therapy after Acute Coronary Syndrome EventCardiology · Lancet · 2026-08-29
RCTn = 67,624 patient presentations
Boeddinghaus et al. Safety and efficacy of the 0/1 h pathway for myocardial infarction in the emergency department: an international, pragmatic, stepped-wedge, cluster-randomised, controlled trialCardiology · J Am Coll Cardiol · 2026-08-28
RCTn = 6,016
Qiu et al. Bivalirudin Versus Heparin in Low and Non-Low Bleeding Risk Patients Undergoing Primary PCI for STEMI: The BRIGHT-4 TrialCardiology · Circulation · 2026-08-28
RCTn = 400
Hasific et al. Vitamin K2 and D3 Supplementation in Patients With Severe Coronary Artery Calcification: The DANCODE TrialCardiology · Circulation · 2026-08-18
Secondary analysisn = 17,604
Plutzky et al. Effect of Semaglutide on the Inflammatory Biomarker High-Sensitivity CRP in Patients With Established Cardiovascular Disease and Overweight or Obesity in SELECT: A Prespecified Secondary Analysis